Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Gossamer Bio Inc (GOSS)

Gossamer Bio Inc (GOSS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 203,303
  • Shares Outstanding, K 226,219
  • Annual Sales, $ 0 K
  • Annual Income, $ -179,820 K
  • 60-Month Beta 1.95
  • Price/Sales 2.04
  • Price/Cash Flow N/A
  • Price/Book 2.56
Trade GOSS with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.39
  • Most Recent Earnings $0.22 on 08/12/24
  • Next Earnings Date 08/13/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 98.21% ( -226.79%)
  • Historical Volatility 57.06%
  • IV Percentile 36%
  • IV Rank 26.98%
  • IV High 346.99% on 04/17/24
  • IV Low 6.27% on 06/13/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 5,273
  • Volume Avg (30-Day) 481
  • Put/Call OI Ratio 0.43
  • Today's Open Interest 30,573
  • Open Int (30-Day) 28,978

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.18
  • Number of Estimates 5
  • High Estimate -0.12
  • Low Estimate -0.21
  • Prior Year -0.21
  • Growth Rate Est. (year over year) +14.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8217 +10.88%
on 08/29/24
0.9754 -6.59%
on 09/06/24
+0.0613 (+7.21%)
since 08/16/24
3-Month
0.5500 +65.65%
on 06/20/24
1.3700 -33.50%
on 07/11/24
+0.3687 (+67.98%)
since 06/18/24
52-Week
0.4525 +101.35%
on 10/24/23
1.6000 -43.06%
on 03/07/24
-0.0319 (-3.38%)
since 09/18/23

Most Recent Stories

More News
Gossamer Bio: Q2 Earnings Snapshot

Gossamer Bio: Q2 Earnings Snapshot

GOSS : 0.9111 (+1.38%)
Gossamer Bio: Q1 Earnings Snapshot

Gossamer Bio: Q1 Earnings Snapshot

GOSS : 0.9111 (+1.38%)
Gossamer Bio: Q4 Earnings Snapshot

Gossamer Bio: Q4 Earnings Snapshot

GOSS : 0.9111 (+1.38%)
Gossamer Bio: Q3 Earnings Snapshot

Gossamer Bio: Q3 Earnings Snapshot

GOSS : 0.9111 (+1.38%)
Gossamer Bio: Q2 Earnings Snapshot

Gossamer Bio: Q2 Earnings Snapshot

GOSS : 0.9111 (+1.38%)
Gossamer Bio: Q1 Earnings Snapshot

Gossamer Bio: Q1 Earnings Snapshot

GOSS : 0.9111 (+1.38%)
Gossamer Bio: Q4 Earnings Snapshot

Gossamer Bio: Q4 Earnings Snapshot

GOSS : 0.9111 (+1.38%)
Gossamer Bio Announces Fourth Quarter and Full-Year 2022 Financial Results and Provides Business Update

Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation...

GOSS : 0.9111 (+1.38%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gossamer Bio, Inc. - GOSS

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Gossamer Bio, Inc. ("Gossamer" or the "Company") (NASDAQ: GOSS). Such investors...

GOSS : 0.9111 (+1.38%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gossamer Bio, Inc. - GOSS

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Gossamer Bio, Inc. ("Gossamer" or the "Company") (NASDAQ: GOSS). Such investors...

GOSS : 0.9111 (+1.38%)

Business Summary

Gossamer Bio Inc. is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing and commercializing therapeutics in the areas of immunology, inflammation and oncology. The company's product pipeline includes GB001, GB002, GB004, GB1275, Autoimmune program and Oncology...

See More

Key Turning Points

3rd Resistance Point 1.0627
2nd Resistance Point 1.0164
1st Resistance Point 0.9637
Last Price 0.9111
1st Support Level 0.8647
2nd Support Level 0.8184
3rd Support Level 0.7657

See More

52-Week High 1.6000
Fibonacci 61.8% 1.1617
Fibonacci 50% 1.0263
Last Price 0.9111
Fibonacci 38.2% 0.8908
52-Week Low 0.4525

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar